Skip to main content
TipRanks
Go Ultimate75% OFF

BB Biotech (0JYO) Share Price & Analysis

4 Followers

0JYO Stock Chart & Stats

CHF 52.50-CHF 1.50(-2.78%)
At close: 4:30 PM GMT
CHF47.5CHF50CHF52.5CHF55Aug 24Sep 7Sep 21Oct 5Oct 19Nov 2Nov 16
Day’s Range
CHF 52.50 - CHF 54.20
52-Week Range
CHF 41.10 - CHF 56.90
Previous Close
CHF 54.00
Volume
N/A
Average Volume (3M)
6,808
Market Cap
CHF 2.95B
Enterprise Value
-CHF 433.37M
Total Cash (Recent Filing)
CHF 3.30B
Total Debt (Recent Filing)
CHF 0
Price to Earnings (P/E)
2.8
Beta
0.93
Next Earnings
Jan 22, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
4.18%

Bulls Say, Bears Say

Bulls Say

Debt-free Balance Sheet

A debt-free structure and equity that nearly matches assets provide substantial financial resilience. BB Biotech has limited leverage-related obligations, allowing its portfolio strategy to withstand investment swings while preserving flexibility for capital allocation and shareholder distributions.

Strong Profitability Rebound

The sharp TTM improvement demonstrates that the portfolio can generate substantial earnings when underlying biotech holdings perform well. This rebound strengthens near-term capital resources and shows meaningful earnings power, even though the investment model remains cyclical and results can vary.

Positive Cash Generation

Recent operating and free cash flow of 195.9M indicates that BB Biotech is currently converting its investment activity into significant cash resources. Positive cash generation supports ongoing portfolio management, financial resilience, and the capacity to maintain shareholder returns.

Bears Say

High Earnings Volatility

The return to strong profitability has not established a stable earnings base because earlier periods included large losses and abnormal margins. Dependence on portfolio valuation movements makes future income harder to forecast and can produce substantial swings across reporting periods.

Declining Free Cash Flow

Although current cash generation is positive, the meaningful year-over-year decline and prior negative periods indicate that cash conversion is inconsistent across cycles. This variability can complicate distribution planning and reduce confidence that recent cash resources will persist.

Concentrated Portfolio Exposure

A concentrated portfolio can increase the effect of individual holdings and biotech-sector outcomes on company performance. Because BB Biotech relies on research-driven security selection rather than diversified operating revenue, adverse developments in selected investments may have an outsized impact.

BB Biotech News

0JYO FAQ

What was BB Biotech’s price range in the past 12 months?
BB Biotech lowest share price was CHF41.10 and its highest was CHF56.90 in the past 12 months.
What is BB Biotech’s market cap?
BB Biotech’s market cap is CHF2.95B.
When is BB Biotech’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were BB Biotech’s earnings last quarter?
BB Biotech released its earnings results on Oct 23, 2026. The company reported CHF3.174 earnings per share for the quarter.
Is BB Biotech overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does BB Biotech pay dividends?
BB Biotech does not currently pay dividends.
What is BB Biotech’s EPS estimate?
BB Biotech’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BB Biotech have?
BB Biotech has 55,149,250 shares outstanding.
What happened to BB Biotech’s price movement after its last earnings report?
BB Biotech reported an EPS of CHF3.174 in its last earnings report. Following the earnings report the stock price went down -2.068%.
Which hedge fund is a major shareholder of BB Biotech?
Currently, no hedge funds are holding shares in GB:0JYO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology